Clinical Trial Update: HD16 for Early Stage Hodgkin Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 trial update for HD16 in early-stage Hodgkin lymphoma is reported, with status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: University of Cologne | Conditions: Hodgkin Lymphoma | Phase 3 | Status: UNKNOWN